"Centro de atención médica a pacientes y familiares con condiciones reumáticas."

During the past decade, Centro Reumatologico Caguas conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Reumatologico Caguas" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centro Reumatologico Caguas" are "Rheumatoid Arthritis" (3 trials), "Systemic Lupus Erythematosus" (2 trials), "Arthritis" (1 trials), "Autoimmune Diseases" (1 trials) and "Connective Tissue Diseases" (1 trials). Many other conditions were trialed in "Centro Reumatologico Caguas" in a lesser frequency.

Most popular intervention types in "Centro Reumatologico Caguas" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BIIB059 (litifilimab)" (1 trials), "Baricitinib" (1 trials), "LY3361237" (1 trials) and "LY3462817" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Reumatologico Caguas" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Centro Reumatologico Caguas". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centro Reumatologico Caguas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Reumatologico Caguas, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".